Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download 
|
< Back |
| 10 Jul 2024 | |
| Resignation of Mr. Mehul Patel from the post of Chief Financial Officer of the Company with effect from July 10, 2024, Appointment of Ms. Anar Jayesh Patel (DIN: 02588388 ), as Additional Director (Whole-time Director), liable to retire by rotation, designated as Executive Director for a period of 5 years with effect from July 10, 2024 to July 09, 2029 and appointment of Mr. Jitendra Somchand Shah ( DIN: 01609325), as an Additional Director categorized as Non - Executive Independent Director of the Company, for a term of 5 consecutive years w.e.f. July 10, 2024 to July 9 2029 | |
| View all announcements for Shukra Pharmaceuticals Ltd | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback